"Walk me through how a company defends itself against a hostile takeover" is a standard M&A interview question, and it's a question with a wrong way and a right way to answer it. The wrong way is to list buzzwords — poison pill, white knight, staggered board — without being able to show how any of them actually change the numbers. The right way is to pick one defense, usually the poison pill, and demonstrate the mechanics with real figures.

The Framework Interviewers Expect

A strong answer moves through three layers, in order:

  • The threat: quantify the hostile bid itself — offer price, premium over the pre-bid share price, and total deal value. This is the number every defense gets measured against.
  • The mechanism: pick a specific defense and show exactly how it changes the acquirer's position — for a poison pill, that means computing the acquirer's ownership percentage before and after the rights plan is triggered, not just asserting that "dilution happens."
  • The outcome: connect the mechanism back to leverage — why does diluting the acquirer's stake change its incentives, and what does the board do with the time and leverage it buys (negotiate a higher price, find a white knight, or simply wait the acquirer out)?

Common Interview Questions and How to Structure Your Answer

"What is a poison pill and how does it work?" Define it as a shareholder rights plan that lets every shareholder except the acquirer buy new shares at a discount once a trigger threshold is crossed, then immediately move to the effect: the acquirer's stake gets diluted without the acquirer selling anything, which is what makes continued open-market accumulation uneconomical.

"How much does a poison pill actually dilute an acquirer?" This is where most candidates go vague. Don't. Walk through an example: a 12% toehold stake, a rights plan that doubles every other shareholder's holdings, and the resulting ownership drop to around 6% — nearly halved. We work through this exact calculation, with a full data table and formulas, in Hostile Takeover and Defense Tactics.

"What's the difference between a poison pill and a staggered board?" A pill attacks the economics of accumulating shares; a staggered board attacks the timeline of gaining board control, since only a fraction of directors face election each year. Interviewers are checking that you don't conflate the two — they're often deployed together but solve different problems for the target.

"When would a board bring in a white knight instead of just fighting the bid?" When the board concludes shareholders are better served by a friendlier, higher offer than by simply resisting — a white knight offer at a bigger premium than the hostile bid gives the board a way to satisfy its fiduciary duty while avoiding a change of control on the original bidder's terms.

Worked Example: Pricing the Defense

To practice putting numbers behind the theory, work through Hostile Takeover and Defense Tactics: it prices a hostile bid, computes the acquirer's ownership before and after a poison pill triggers, and prices a competing white knight offer — the exact sequence an interviewer is listening for. For the related question of how a target structures the consideration it's fighting over, see Cash vs. Stock Consideration.

Mistakes That Signal You Don't Understand the Mechanics

  • Saying a poison pill "blocks" a takeover — it doesn't; it's a negotiating lever the board can redeem at will.
  • Forgetting the acquirer is excluded from the rights plan, which is precisely what causes the dilution.
  • Treating every defense as permanently available — courts require defensive measures to be proportionate to the actual threat, so an interviewer may push on when a board should not deploy a pill.